WO2008142701A1 - Method of preparation and preservation of soy bean curd with preserved poly unsaturated fatty acid - Google Patents
Method of preparation and preservation of soy bean curd with preserved poly unsaturated fatty acid Download PDFInfo
- Publication number
- WO2008142701A1 WO2008142701A1 PCT/IN2007/000202 IN2007000202W WO2008142701A1 WO 2008142701 A1 WO2008142701 A1 WO 2008142701A1 IN 2007000202 W IN2007000202 W IN 2007000202W WO 2008142701 A1 WO2008142701 A1 WO 2008142701A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- soy
- curd
- preparation
- soy curd
- set forth
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title claims abstract description 14
- 238000004321 preservation Methods 0.000 title claims abstract description 14
- 235000013527 bean curd Nutrition 0.000 title description 10
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 84
- 244000068988 Glycine max Species 0.000 claims abstract description 26
- 230000008569 process Effects 0.000 claims abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 12
- 201000010099 disease Diseases 0.000 claims abstract description 11
- 235000013322 soy milk Nutrition 0.000 claims abstract description 11
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 10
- 238000002791 soaking Methods 0.000 claims abstract description 10
- 201000011510 cancer Diseases 0.000 claims abstract description 9
- 208000019622 heart disease Diseases 0.000 claims abstract description 8
- 206010027304 Menopausal symptoms Diseases 0.000 claims abstract description 7
- 201000004681 Psoriasis Diseases 0.000 claims abstract description 7
- 208000001647 Renal Insufficiency Diseases 0.000 claims abstract description 7
- 208000025865 Ulcer Diseases 0.000 claims abstract description 7
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 7
- 201000006370 kidney failure Diseases 0.000 claims abstract description 7
- 231100000397 ulcer Toxicity 0.000 claims abstract description 7
- 208000007848 Alcoholism Diseases 0.000 claims abstract description 6
- 201000004624 Dermatitis Diseases 0.000 claims abstract description 6
- 206010020772 Hypertension Diseases 0.000 claims abstract description 6
- 201000007930 alcohol dependence Diseases 0.000 claims abstract description 6
- 208000006673 asthma Diseases 0.000 claims abstract description 6
- 208000010668 atopic eczema Diseases 0.000 claims abstract description 6
- 208000030533 eye disease Diseases 0.000 claims abstract description 6
- 206010039073 rheumatoid arthritis Diseases 0.000 claims abstract description 6
- 201000008827 tuberculosis Diseases 0.000 claims abstract description 6
- 208000016261 weight loss Diseases 0.000 claims abstract description 6
- 230000004580 weight loss Effects 0.000 claims abstract description 6
- 238000000855 fermentation Methods 0.000 claims abstract description 5
- 230000004151 fermentation Effects 0.000 claims abstract description 5
- 238000000227 grinding Methods 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 238000012545 processing Methods 0.000 claims abstract description 3
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 25
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 20
- 229940068041 phytic acid Drugs 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 235000002949 phytic acid Nutrition 0.000 claims description 11
- 235000013336 milk Nutrition 0.000 claims description 9
- 239000008267 milk Substances 0.000 claims description 9
- 210000004080 milk Anatomy 0.000 claims description 9
- 235000005979 Citrus limon Nutrition 0.000 claims description 8
- 244000131522 Citrus pyriformis Species 0.000 claims description 8
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 8
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 239000000467 phytic acid Substances 0.000 claims description 8
- 108010073771 Soybean Proteins Proteins 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 229940001941 soy protein Drugs 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 235000002864 food coloring agent Nutrition 0.000 claims description 2
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 2
- 239000008122 artificial sweetener Substances 0.000 claims 1
- 235000021311 artificial sweeteners Nutrition 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 229930003944 flavone Natural products 0.000 claims 1
- 150000002213 flavones Chemical class 0.000 claims 1
- 235000011949 flavones Nutrition 0.000 claims 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims 1
- 238000010025 steaming Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 13
- 235000013305 food Nutrition 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 4
- 229940012843 omega-3 fatty acid Drugs 0.000 description 4
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 4
- 229940033080 omega-6 fatty acid Drugs 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 150000002515 isoflavone derivatives Chemical class 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000003075 phytoestrogen Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- OEUUFNIKLCFNLN-LLVKDONJSA-N chembl432481 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC(O)=CC=2)O)=N1 OEUUFNIKLCFNLN-LLVKDONJSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000021027 japanese diet Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 238000012144 step-by-step procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/40—Pulse curds
- A23L11/45—Soy bean curds, e.g. tofu
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to the preparation and preservation of soy bean curd and invention of preserved poly unsaturated fatty acid: omega 3 and Omega 6 in a particular proportion from soybean when treated by an invented method, which can used as a food supplement for the treatment of various diseases like kidney failure,
- HIV HIV, diabetics, cancer, high blood pressure and heart diseases, rheumatoid arthritis, psoriasis, asthma, eye disease, menopausal symptoms, eczema, tuberculosis, ulcers, weight loss and alcoholism
- soybean is used probably only as soybean curd or tofu, since it has so many negative sides. But in Soybean curd there is no negative side since it undergoes certain treatment and processing for the preparation of curd. But the traditional method of making soy curd does not include the preservation of it. It can be only for immediate use. That is, there is no chance for preparing bulk quantity. Cell wall membranes contain large quantities of polyunsaturated fatty acids.
- the body uses saturated fatty acids, if it lacks sufficient amounts of polyunsaturated fatty acid. This could happen if the diet is high in saturated fats and low in polyunsaturated fats.
- the membrane that is formed will not have the same properties as one made up of polyunsaturated fatty acids. In long term this can lead to health problems and disease such as kidney failure, HIV, diabetics, cancer high blood pressure and heart diseases, rheumatoid arthritis, psoriasis, asthma, eye disease, menopausal symptoms, eczema, tuberculosis, ulcers, weight loss and alcoholism.
- Omega 3 and Omega 6 fatty acid are not inter convertible in the human body.
- omega 3 fatty acids When diets are supplemented with omega 3 fatty acids, the latter partially replace the omega 6 fatty acids in the membranes of practically all cells. Therefore, getting the right amount of each group of PUFAs influences every major organ and system in our body. So there is a need of food supplement, which helps the body getting the right amount of PUFAs
- the present invention is a new and improved method of preparation of Soya curd which can be preserved for weeks, and can be used as a food supplement for the treatment of various diseases such as Kidney failure, Diabetics,, Cancer, High Blood Pressure and Heart diseases, Rheumatoid arthritis, Psoriasis, Asthma, Eye Disease, menopausal symptoms, Eczema, Tuberculosis, Ulcers, Weight Loss, Alcoholism etc.
- diseases such as Kidney failure, Diabetics,, Cancer, High Blood Pressure and Heart diseases, Rheumatoid arthritis, Psoriasis, Asthma, Eye Disease, menopausal symptoms, Eczema, Tuberculosis, Ulcers, Weight Loss, Alcoholism etc.
- the first step of traditional method of making soy curd or tofu is making of soymilk.
- soymilk whole soybeans were soaked in water for 10 hours, drained and rinsed several times. The hydrated soybeans were combined with water (1 part soybeans to 10 parts water). The soybeans/water mixture was then ground in a waring blender on medium speed for one minute. The resulting slurry was immediately transferred into a glass flask and placed in a boiling water bath. The soybean slurry was stirred and brought to 85°C. Within 8 minutes where it was held for 15 minutes. The soymilk was then cooled to 40 0 C in an ice bath, filtered through cheesecloth, bottled and refrigerated (4°C).
- L-cystine was added directly to the process water prior to adding the soybeans to achieve an overall concentration of 300 ppm. After add citric acid or any other acid to make soy curd and drained all water from soy curd, to keep it as tofu.
- the present invention is generally directed to soy curd and the process for preparation of soy curd and preservation of it.
- the process described herein includes the preparation and preservation of soy curd.
- this new method of preparation of soy curd include a step by step procedure like selection of soy bean, soaking it in water
- health problems and disease such as kidney failure, HIV, diabetics, cancer, high blood pressure and heart diseases, rheumatoid arthritis, psoriasis, asthma, eye disease, menopausal symptoms, eczema, tuberculosis, ulcers, weight loss and alcoholism.
- IP 6 is a polyphosphorylated carbohydrate, contained in high concentrations (0.4- 6.4%) in cereals and legumes.
- the small amount of phytic acid (IP 6 or inositol hexaphosphate also InsP 6 ) is very useful to human body. IP6 is found in every cell in the body and is essential for life. By virtue of its ubiquitous presence in living human
- IP6 inositol hexaphosphate
- IP6 inositol hexaphosphate
- phytic acid is used as a preservative with E number E391 125 130 Soy curd decreases risk for heart disease by helping to lower density blood cholesterol levels. It plays a crucial role in lowering risk for various diseases.
- Soy protein can reduce plasma concentrations of total and LDL cholesterol but does not adversely affect levels of HDL, or "good" cholesterol, which at high levels has 135 been associated with a reduction in heart disease risk
- Soybeans also contain potentially healthful compounds called phytoestrogens (also known as isoflavones), such as genestein, diadzein and others that are weak-acting estrogens.
- phytoestrogens also known as isoflavones
- Phytoestrogens occupy estrogen receptors and thereby reduce the effect of 140 one's potentially more potent endogenous (made in the body) estrogens
- Figure 1 is the test report of Soya curd fatty acid composition such as saturated, 145 monounsaturated, polyunsaturated fatty acid
- Figure 2 is the analytical results of soy bean curd
- the present invention is generally directed to soy curd and the new and improved method of preparation of soy curd and preservation of it, which can be used as food supplement for various diseases.
- Soy curd is the most popular product among all the soy products with the highest therapeutically value.
- the new and invented method is a
- the first step of the process includes collection of soybeans, and it is very important step since it helps to maintain the quality of the soy curd.
- this method of preparation it is better to use organic beans, especially organic seed of range 80-- 105 165 days maturity, in particular of range 85 - 95 days.
- organic bean especially organic seed is essential because it maintain the quality of the curd helps skin breathing and our blood keep cool. It is necessary to collect good quality organic soy bean seed which do not have any fungus or any 170 damage and it should be one time crop of the same size of range 4mm-5mm(i.e. it should pass through a sieve of 5mm) to get same quality seeds. Golden colour seed is preferred.
- Soak the bean herein after termed as seed or bean or soybean, for 5 hours in fresh and
- the soybean is fed into a machine for the preparation of soymilk by adding 10- 10.5-litre water for 1 Kg beans. In that process it will steam the milk up to 115 0 C using the same machine. Let it be cool, the range of temperature be 20° -
- soy curd can use for further production of soy curd. That is 1 litre of soy curd is 190 used for 12 liters soy milk. That is after the preparation of the soy milk add 1 litre and its multiple of soy curd to 121itre and its multiple of soymilk at the desirable temperature of 22°C. 195
- the curd is ready for use after 12 hours. It should be keep without air contact. Keeping the curd without air contact will help to preserve the curd.
- the preservation of the curd is possible from 30 to 90 days without preservative and under normal room temperature. More accurately, it can preserve up to 60 days under a temperature
- Fat content in 500 ml soy curd is only 2% and there is no artificial sweetners or synthetic food colour is added.
- the solid content is 6.6%.
- Isoflavones metabolized by gut mycroflora. Stomach acid also helps in the process. Genestin, which is a healing factor stabilizes the abdominal temperature as 37°C, increases the number of CD 4+ cells in blood and also eliminates uric acid.
- Soy curd The protein present in Soy curd is the most balanced protein for human consumption. 500 ml of Soy curd provide approximately 10 gms of Soy protein. It contains all the nine essential amino acids required for the body from the dietary source.
- Soy protein causes calcium to be better utilized to minimize the risk of osteoporosis. 220 Also consumption of soy curd decreases menopausal symptoms i.e., hot flashes, night sweats, pain in the lower back and muscle joints and other discomforts.
- Diabetes is a disorder of metabolism. Sufficient amount of polyunsaturated fatty acids 230 like Omega 3 and Omega 6 fatty acids are very much essential for the optimum metabolism of the human system.
- Soy curd The Components of fatty acid in 500 ml Soy curd are saturated FA C 16.0 (12.74 %) and C18.0(2.88%) ,Monounsaturated FA C18.1(24.68), Polyunsaturated FA 235 Cl 8.2(52.92) Cl 8.3(6.76). In soy curd fatty acids are fully preserved and can utilize it while having the curd.
- appetite is felt one and a half hour before the schedule time of food intake, amount has to be increased in the following days. If gas formation, acidity or chest burning is 250 felt take 4 glasses of lukewarm water after defecation in the morning. Also take water 30 mts before food and take Soy curd along with food. Take rest after food. This curd is very effective for HIV affected patient also and it helps to improve the CD4 + cells
- Example 5 A diabetic patient of age 53 had this curd for 3yrs and cured completely from diabetics and related diseases.
- a female patient of 24yrs with a weight of 102 Kg was in a severe condition and suggested for an operation in brain takes this curd and get a change after 30 days.
- An AIDS Patient of age 48 takes the curd for 3 months and gained a good health. His CD4+ cells count came to 270.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Beans For Foods Or Fodder (AREA)
Abstract
A process for preparing soy curd by an inventive method and preservation of it. The process comprising the selection of soy bean, soaking method, grinding and preparation of soy milk, making of soy curd for the fermentation, final processing of soy curd and invention of preserved poly unsaturated fatty acid, omega 3 and omega 6 in a particular proportion from soybean. When treated by an invented method, which can be used as a food supplement for the treatment of various diseases like kidney failure, HIV, diabetics, cancer high blood pressure and heart diseases, rheumatoid arthritis, psoriasis, asthma, eye disease, menopausal symptoms, eczema, tuberculosis, ulcers, weight loss and alcoholism.
Description
METHOD OF PREPARATION AND PRESERVATION OF SOY BEAN CURD WITH PRESERVED POLY UNSATURATED FATTY ACID
FIELD OF THE INVENTION
The present invention relates to the preparation and preservation of soy bean curd and invention of preserved poly unsaturated fatty acid: omega 3 and Omega 6 in a particular proportion from soybean when treated by an invented method, which can used as a food supplement for the treatment of various diseases like kidney failure,
HIV, diabetics, cancer, high blood pressure and heart diseases, rheumatoid arthritis, psoriasis, asthma, eye disease, menopausal symptoms, eczema, tuberculosis, ulcers, weight loss and alcoholism
BACKGROUND AND PRIOR ART OF THE INVENTION
Good Health for all is a dream and only a dream in this world. To attain this, is very difficult and we can say that it is not possible. To overcome this situation, several research and studies had undergone and now it reached at Poly unsaturated fatty acids and soybean. Traditionally, soybean is used probably only as soybean curd or tofu, since it has so many negative sides. But in Soybean curd there is no negative side since it undergoes certain treatment and processing for the preparation of curd. But the traditional method of making soy curd does not include the preservation of it. It can be only for immediate use. That is, there is no chance for preparing bulk quantity. Cell wall membranes contain large quantities of polyunsaturated fatty acids. As cells are being formed, the body uses saturated fatty acids, if it lacks sufficient amounts of polyunsaturated fatty acid. This could happen if the diet is high in saturated fats and low in polyunsaturated fats. The membrane that is formed will not have the same properties as one made up of polyunsaturated fatty acids. In long term this can lead to health problems and disease such as kidney failure, HIV, diabetics, cancer high blood pressure and heart diseases, rheumatoid arthritis, psoriasis, asthma, eye disease, menopausal symptoms, eczema, tuberculosis, ulcers, weight loss and alcoholism.
There are two distinct groups of polyunsaturated fatty acids - omega 3 and omega 6 fatty acid. Both are important components of practically all cell membranes. Omega 3 and Omega 6 fatty acid are not inter convertible in the human body. When diets are supplemented with omega 3 fatty acids, the latter partially replace the omega 6 fatty acids in the membranes of practically all cells. Therefore, getting the right amount of each group of PUFAs influences every major organ and system in our body. So there is a need of food supplement, which helps the body getting the right amount of PUFAs
The present invention is a new and improved method of preparation of Soya curd which can be preserved for weeks, and can be used as a food supplement for the treatment of various diseases such as Kidney failure, Diabetics,, Cancer, High Blood Pressure and Heart diseases, Rheumatoid arthritis, Psoriasis, Asthma, Eye Disease, menopausal symptoms, Eczema, Tuberculosis, Ulcers, Weight Loss, Alcoholism etc.
The first step of traditional method of making soy curd or tofu is making of soymilk. For soymilk, whole soybeans were soaked in water for 10 hours, drained and rinsed several times. The hydrated soybeans were combined with water (1 part soybeans to 10 parts water). The soybeans/water mixture was then ground in a waring blender on medium speed for one minute. The resulting slurry was immediately transferred into a glass flask and placed in a boiling water bath. The soybean slurry was stirred and brought to 85°C. Within 8 minutes where it was held for 15 minutes. The soymilk was then cooled to 400C in an ice bath, filtered through cheesecloth, bottled and refrigerated (4°C). L-cystine was added directly to the process water prior to adding the soybeans to achieve an overall concentration of 300 ppm. After add citric acid or any other acid to make soy curd and drained all water from soy curd, to keep it as tofu.
SUMMARY OF THE INVENTION
70
The present invention is generally directed to soy curd and the process for preparation of soy curd and preservation of it. The process described herein includes the preparation and preservation of soy curd. In this new method of preparation of soy curd include a step by step procedure like selection of soy bean, soaking it in water
75 about 6-10 hours, Keeping aside for sprouting for 5 hours, then soaking for 5-7 hours after several wash, grinding and taking the milk using machine and adding correct proportion of lemon juice, formation of Curd after 24 hours. It is not in a solid form, like the traditional type, but the semi solid just like the curd formed from the cow milk. And can consume just like other type curd along with any other food or its
80 alone. This can be taken as a food supplement especially for the patients those who have health problems and disease such as kidney failure, HIV, diabetics, cancer, high blood pressure and heart diseases, rheumatoid arthritis, psoriasis, asthma, eye disease, menopausal symptoms, eczema, tuberculosis, ulcers, weight loss and alcoholism.
85 The traditional Japanese diet had, through centuries of trial and error, found ways to use soybeans in a healthy manner. They did not eat whole soybeans or soy protein isolate. They mainly ate fermented soy products. The fermentation process deactivates both trypsin inhibitors and hemagglutinin, while regular cooking does not. Soy was, in fact, only one component of a diet that included food rich with minerals, vitamins,
90 and other essential nutrients
Scientists are in general agreement that grain- and legume-based diets high in phytates contribute to widespread mineral deficiencies. Only a long period of fermentation will significantly reduce the phytate content of soybeans. In this situation soy bean curd is more beneficial than any other soy products. Reduced level of phytic acid is also 95 needed.
100 A novel anticancer function of phytic acid has been shown both in vivo and in vitro. IP6 is a polyphosphorylated carbohydrate, contained in high concentrations (0.4- 6.4%) in cereals and legumes. The small amount of phytic acid (IP6 or inositol hexaphosphate also InsP6) is very useful to human body. IP6 is found in every cell in the body and is essential for life. By virtue of its ubiquitous presence in living human
105 cells, it is non-toxic. [Richardson DR, Critical review Oncology Hematology 42: 267- 81, 2002]
Nature's most effective iron-chelating molecule is inositol hexaphosphate (IP6), found naturally in seeds and bran. IP6 is a selective agent against cancer cells. Because cancer cells are high in iron content, IP6 directs most of its attention to 110 abnormal cells. IP6 selectively removes iron from tumors cells, which deprives them of their primary growth factor. IP6 does not remove iron from red blood cells, which are tightly bound to hemoglobin. Unlike cancer drugs, healthy cells are not affected with IP6, so IP6 has very low toxicity. [Deliliers GL, British J Haematology 117: 577-87, 2002]
1 15 The obvious choice among available iron chelators is inositol hexaphosphate or IP6. IP6 meets all the requirements for a safe iron chelator to treat cancer. It penetrates inside cells. It is non-toxic, inexpensive, and very effective. It's just not a drug.
Only phytic acid IP6 was found to be economical, nontoxic, and effective. [Graf E, Journal Biological Chemistry 262: 11647-50, 1987]
120 Dietary mineral chelators help prevent over-mineralization of joints, blood vessels, and other parts of the body, which is most common in older persons. The Journal of Environmental Nutrition (April 2004 volume 27 issue 4) has also stated phytic acid may be considered a phytonutrient, providing an antioxidant effect.
As a food additive , phytic acid is used as a preservative with E number E391 125
130 Soy curd decreases risk for heart disease by helping to lower density blood cholesterol levels. It plays a crucial role in lowering risk for various diseases.
Soy protein can reduce plasma concentrations of total and LDL cholesterol but does not adversely affect levels of HDL, or "good" cholesterol, which at high levels has 135 been associated with a reduction in heart disease risk
Soybeans also contain potentially healthful compounds called phytoestrogens (also known as isoflavones), such as genestein, diadzein and others that are weak-acting estrogens. Phytoestrogens occupy estrogen receptors and thereby reduce the effect of 140 one's potentially more potent endogenous (made in the body) estrogens
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is the test report of Soya curd fatty acid composition such as saturated, 145 monounsaturated, polyunsaturated fatty acid
Figure 2 is the analytical results of soy bean curd
DETAILED DESCRIPTION OF THE INVENTION
150
The present invention is generally directed to soy curd and the new and improved method of preparation of soy curd and preservation of it, which can be used as food supplement for various diseases. Soy curd is the most popular product among all the soy products with the highest therapeutically value. The new and invented method is a
155 series of procedure.
160
The first step of the process includes collection of soybeans, and it is very important step since it helps to maintain the quality of the soy curd. In this method of preparation it is better to use organic beans, especially organic seed of range 80-- 105 165 days maturity, in particular of range 85 - 95 days.
The selection of organic bean especially organic seed is essential because it maintain the quality of the curd helps skin breathing and our blood keep cool. It is necessary to collect good quality organic soy bean seed which do not have any fungus or any 170 damage and it should be one time crop of the same size of range 4mm-5mm(i.e. it should pass through a sieve of 5mm) to get same quality seeds. Golden colour seed is preferred.
Soak the bean, herein after termed as seed or bean or soybean, for 5 hours in fresh and
175 pure water such that all the seeds should drowned well in the water. After 5 hours drain the water and put it in a vessel with air holes and keep it aside for another 5 hours for sprouting. The temperature should be between 260C and 32°C. After sprouting wash the seed several times (5-6 times). It help to remove the negative effects of the soybean. Repeat the soaking for another 5-7 hours. Then it is ready for
180 the grinding. The soybean is fed into a machine for the preparation of soymilk by adding 10- 10.5-litre water for 1 Kg beans. In that process it will steam the milk up to 1150C using the same machine. Let it be cool, the range of temperature be 20° -
25°C and more desirable temperature is 220C. Then add lemon juice to the milk at the required proportion. It is better if 70 -80ml of lemon juice is added to 3 ^4 liters
185 milk. More desirably 75 ml lemon juice to 3-41itre of milk. Usually some citric acid or any other acid is using instead of lemon juice. Keep this mixture without air contact or it should be packed without air in HDD pouch. Within 24 hours soy curd is ready.
This soy curd can use for further production of soy curd. That is 1 litre of soy curd is 190 used for 12 liters soy milk. That is after the preparation of the soy milk add 1 litre and its multiple of soy curd to 121itre and its multiple of soymilk at the desirable temperature of 22°C.
195
The curd is ready for use after 12 hours. It should be keep without air contact. Keeping the curd without air contact will help to preserve the curd. The preservation of the curd is possible from 30 to 90 days without preservative and under normal room temperature. More accurately, it can preserve up to 60 days under a temperature
200 of 22°C. It has a long preservation term if it is keep under 100C.
Fat content in 500 ml soy curd is only 2% and there is no artificial sweetners or synthetic food colour is added. The solid content is 6.6%.
205 It has isoflavones concentration of 1.3 to 3.8 mg/g or about 37 to 108 mg per ounce. Isoflavones are metabolized by gut mycroflora. Stomach acid also helps in the process. Genestin, which is a healing factor stabilizes the abdominal temperature as 37°C, increases the number of CD4+ cells in blood and also eliminates uric acid.
210 By consuming the Soya curd it was found that the lipid peroxidation product are less. This shows the ability of soybean curd to decrease the level of lipid peroxidation products. It has an antioxidative effect and it help to prevent free radical formation.
215 The protein present in Soy curd is the most balanced protein for human consumption. 500 ml of Soy curd provide approximately 10 gms of Soy protein. It contains all the nine essential amino acids required for the body from the dietary source.
Soy protein causes calcium to be better utilized to minimize the risk of osteoporosis. 220 Also consumption of soy curd decreases menopausal symptoms i.e., hot flashes, night sweats, pain in the lower back and muscle joints and other discomforts.
225
Diabetes is a disorder of metabolism. Sufficient amount of polyunsaturated fatty acids 230 like Omega 3 and Omega 6 fatty acids are very much essential for the optimum metabolism of the human system.
The Components of fatty acid in 500 ml Soy curd are saturated FA C 16.0 (12.74 %) and C18.0(2.88%) ,Monounsaturated FA C18.1(24.68), Polyunsaturated FA 235 Cl 8.2(52.92) Cl 8.3(6.76). In soy curd fatty acids are fully preserved and can utilize it while having the curd.
In taking of soy curd corrects the metabolism and prevents and control disease like diabetes by applying the following method. Prescribed medicines have to be followed
240 along with the intake of Soy curd. Take 250 ml in the morning and 200ml of Soy curd at noon and night. It can be taken along with the food or after the food. Food timings should be 8 AM, 1 PM, and 8 PM. It helps to maintain the concentration of digestive and slow releases of glucose to the blood stream. After the intake of Soy curd for 7 days blood test has to be made. If blood glucose exceeds 160 ml without taking food
245 the medicine has to be increased. If visible improvements are not shown take 250 ml of Soy curd each time for 21 days, sure results can be expected.
If appetite is felt one and a half hour before the schedule time of food intake, amount has to be increased in the following days. If gas formation, acidity or chest burning is 250 felt take 4 glasses of lukewarm water after defecation in the morning. Also take water 30 mts before food and take Soy curd along with food. Take rest after food. This curd is very effective for HIV affected patient also and it helps to improve the CD4+ cells
Example 1
255 A male, 28 yrs, met with an accident and affected his nervous system and got paralyzed and has only eyes and tongue movement. He had only liquid food. After seven days of having this curd, he was able to move his fingers and after 60 days he ate food without help.
260
Example 2
A psoriasis patient aged 36 got a change after one month and completely cured after
6 months. Another patient of 28 yrs got relief after 15 days of having the curd.
Example 3
After suffering of Ulcers for 8yrs a male patient took this supplementary food for 3months and got full relief from his diseases.
Example 5 A diabetic patient of age 53 had this curd for 3yrs and cured completely from diabetics and related diseases.
Example 6
A female patient of 24yrs with a weight of 102 Kg was in a severe condition and suggested for an operation in brain takes this curd and get a change after 30 days.
Example 7
A male patient of age 47 having a kidney failure, whose weight was 40 Kg, done 37 number of dialysis. Now he is not undergoing dialysis treatment. Another patient of age 37 who had undergone 160 dialysis, is now free from his Kidney problems
Example 8
An AIDS Patient of age 48 takes the curd for 3 months and gained a good health. His CD4+ cells count came to 270.
Claims
1. A process for preparing soy curd by an inventive method and preservation of it. The process comprising the selection of soy bean, soaking method, grinding and preparation of soy milk, making of soy curd for the fermentation, final processing of soy curd.
2. The process of selection of soy beans set forth in claim 1 wherein it includes the selection of organic seeds instead of beans which each and every seed must have same quality.
3. The selection of seeds set forth in claim 2 wherein the organic seed of range 80- 105 days maturity, and in particular of range 85 - 95 days.
4. The selection of seeds set forth in claim 2 wherein it should be one time crop of the same size of range 4mm-5mm.
5. The process of soaking set forth in claim 1 wherein it includes soaking the bean for 5 hours in fresh and pure water such that all the seeds should drowned well in the water. After 5 hours drain the water and put it in a vessel with air holes and keep it aside for another 5 hours for sprouting. . After sprouting wash the seed several times (5-6 times). Repeat the soaking for another 5-7 hours.
6. The process of soaking set forth in claim 5 wherein the room temperature should be between 26°C and 32°C during soaking.
7. The process of grinding set forth in claim 1 wherein by adding 10- 10.5 litre water for 1 Kg beans and the pH level of the water should be 8.
8. The process of preparation of soy milk set forth in claim 1 wherein the process also comprising the steaming the milk up to 1 15°C and cooling, the range of temperature should be 20° -250C and more desirable temperature is 22°C.
9. The process of preparation of soy curd for fermentation set forth in claim 1 wherein the process comprising of adding lemon juice to the milk at the required proportion. It is better if 70 -80ml of lemon juice is added to 3 -4 litres milk. More desirably 75 ml lemon juice to 3-4 litres of milk. And keeping this mixture without air contact.
10. The process of preparation of soy curd set forth in claim 1 is that 1 litre of soy curd is used for 12 liters soy milk for the further preparation of the soy curd at the desirable temperature of 220C. The curd is ready for use after 12 hours.
11. The process of preservation set forth in claim 1 is that keeping the curd without air contact and the content of phytic acid will help to preserve the curd. The preservation of the curd is possible from 30 to 90 days without preservative and under normal room temperature. More accurately, it can preserve up to 60 days under a temperature of 22°C. It has a long preservation term if it is keep under 100C.
12. The soy curd preparation claimed in claim 1 wherein the fat content in 500 ml soy curd is only 2% and there are no artificial sweeteners or synthetic food colour is added.
13. The soy curd preparation claimed in claim 1 wherein the solid content is 6.6%.
14. The soy curd preparation claimed in claim 1 wherein the soy curd contains is flavones and has concentration of 1.3 to 3.8 mg/g or about 37 to 108 mg per ounce.
15. The soy curd preparation claimed in claim 1 wherein 500 ml of Soy curd provide approximately 10 grams of Soy protein.
16. The soy curd preparation claimed in claim 1 wherein 500 ml of soy curd Comprises of saturated fatty acid C16.0 (12.74 %) and C18.0 (2.88%)
17. The soy curd preparation claimed in claim 1 wherein 500 ml of soy curd Comprises of Monounsaturated fatty acid Cl 8.1 (24.68%).
18. The soy curd preparation claimed in claim 1 wherein 500 ml of soy curd Comprises of Polyunsaturated fatty acid C18.2 (52.92%) and C18.3 (6.76%)
19. The soy curd preparation claimed in claim 1 wherein which can be used as a food supplement for the treatment of various diseases like kidney failure, HIV, diabetics, cancer high blood pressure and heart diseases, rheumatoid arthritis, psoriasis, asthma, eye disease, menopausal symptoms, eczema, tuberculosis, ulcers, weight loss and alcoholism
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1053CH2007 | 2007-05-21 | ||
IN1053/CHE/2007 | 2007-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008142701A1 true WO2008142701A1 (en) | 2008-11-27 |
Family
ID=39712374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2007/000202 WO2008142701A1 (en) | 2007-05-21 | 2007-05-21 | Method of preparation and preservation of soy bean curd with preserved poly unsaturated fatty acid |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008142701A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200038339A1 (en) * | 2016-10-06 | 2020-02-06 | Dy Natural Co., Ltd | Composition for alleviating, preventing or treating female menopausal symptoms, containing, as active ingredient, pinitol, d-chiro-inositol or analog compounds thereof |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3743516A (en) * | 1970-12-01 | 1973-07-03 | Hong Kong Soya Bean | Preparation of cheese from soybean milk |
US4105803A (en) * | 1977-05-02 | 1978-08-08 | Ohio Agricultural Research And Development Center | Soybean-cheese whey food product |
JPH10210947A (en) * | 1997-01-30 | 1998-08-11 | Shuichi Shiomi | Bean curd containing lactic acid bacteria, soymilk containing lactic acid bacteria, soymilk fermented object and manufacture thereof |
KR20010003031A (en) * | 1999-06-19 | 2001-01-15 | 민대동 | Aaaaa |
CN1289554A (en) * | 2000-10-31 | 2001-04-04 | 刘继明 | Dried stewed soybean curd |
KR20040003393A (en) * | 2002-07-02 | 2004-01-13 | 지승용 | Functional Tofu Manufacturing Method |
KR20040064510A (en) * | 2003-01-13 | 2004-07-19 | (주)행림원 | a |
KR20050013383A (en) * | 2003-07-28 | 2005-02-04 | 이보균 | method for manufacturing the functional bean curb including the DHA and EPA |
KR20050111667A (en) * | 2004-05-21 | 2005-11-28 | 주식회사 엠디바이오알파 | Soybean extract of enhancing biosynthesis of hyaluronic acid and glycosaminoglycan |
US20070092588A1 (en) * | 2005-10-21 | 2007-04-26 | The Nisshin Oillio Group, Inc. | Soy milk made from germinated soy beans |
-
2007
- 2007-05-21 WO PCT/IN2007/000202 patent/WO2008142701A1/en active Application Filing
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3743516A (en) * | 1970-12-01 | 1973-07-03 | Hong Kong Soya Bean | Preparation of cheese from soybean milk |
US4105803A (en) * | 1977-05-02 | 1978-08-08 | Ohio Agricultural Research And Development Center | Soybean-cheese whey food product |
JPH10210947A (en) * | 1997-01-30 | 1998-08-11 | Shuichi Shiomi | Bean curd containing lactic acid bacteria, soymilk containing lactic acid bacteria, soymilk fermented object and manufacture thereof |
KR20010003031A (en) * | 1999-06-19 | 2001-01-15 | 민대동 | Aaaaa |
CN1289554A (en) * | 2000-10-31 | 2001-04-04 | 刘继明 | Dried stewed soybean curd |
KR20040003393A (en) * | 2002-07-02 | 2004-01-13 | 지승용 | Functional Tofu Manufacturing Method |
KR20040064510A (en) * | 2003-01-13 | 2004-07-19 | (주)행림원 | a |
KR20050013383A (en) * | 2003-07-28 | 2005-02-04 | 이보균 | method for manufacturing the functional bean curb including the DHA and EPA |
KR20050111667A (en) * | 2004-05-21 | 2005-11-28 | 주식회사 엠디바이오알파 | Soybean extract of enhancing biosynthesis of hyaluronic acid and glycosaminoglycan |
US20070092588A1 (en) * | 2005-10-21 | 2007-04-26 | The Nisshin Oillio Group, Inc. | Soy milk made from germinated soy beans |
Non-Patent Citations (7)
Title |
---|
CHOI ET AL: "Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells", LIFE SCIENCES, PERGAMON PRESS, OXFORD, GB, vol. 80, no. 15, 12 March 2007 (2007-03-12), pages 1403 - 1408, XP005923324, ISSN: 0024-3205 * |
DATABASE WPI Week 200140, Derwent World Patents Index; AN 2001-375703, XP002498321 * |
DATABASE WPI Week 200147, Derwent World Patents Index; AN 2001-439165, XP002498317 * |
DATABASE WPI Week 200435, Derwent World Patents Index; AN 2004-370379, XP002498320 * |
DATABASE WPI Week 200480, Derwent World Patents Index; AN 2004-811464, XP002498319 * |
DATABASE WPI Week 200546, Derwent World Patents Index; AN 2005-453476, XP002498318 * |
DATABASE WPI Week 200678, Derwent World Patents Index; AN 2006-762299, XP002498322 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200038339A1 (en) * | 2016-10-06 | 2020-02-06 | Dy Natural Co., Ltd | Composition for alleviating, preventing or treating female menopausal symptoms, containing, as active ingredient, pinitol, d-chiro-inositol or analog compounds thereof |
US11040016B2 (en) * | 2016-10-06 | 2021-06-22 | Dy Natural Co., Ltd | Composition for alleviating, preventing or treating female menopausal symptoms, containing, as active ingredient, pinitol, D-chiro-inositol or analog compounds thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | The nutritional ingredients and antioxidant activity of donkey milk and donkey milk powder | |
CN101156679B (en) | Rice bran nutrition stock solution and its preparation method | |
US20020187204A1 (en) | Diet composition and method of weight management | |
CN111084381A (en) | Ketogenic nutritional meal replacement powder and application | |
CN109042881B (en) | Sports fermented dairy product and preparation method thereof | |
CN110338402A (en) | A kind of compound probiotic powder and preparation method thereof | |
CN104171025A (en) | Selenium-rich edible oil suitable for women and children | |
CN110037113A (en) | A kind of Ms's weight reducing face-beautifying milk powder | |
AU2012204109A1 (en) | Nutritional composition and method of making | |
CN107279296A (en) | A kind of formula food of suitable diabetes and preparation method thereof | |
CN103610144A (en) | Walnut powder with blood glucose reduction effect and preparation method thereof | |
CN103609701A (en) | Yoghourt suitable for patients with fatty liver to drink and processing process | |
KR20110119305A (en) | A functional beverage comprising taurine, royal jelly, red ginseng, lycii fructus, glumate and apple essence as main ingredients | |
CN105707681A (en) | Supermicro black fungus nutrient porridge with blood sugar reducing function and making method thereof | |
CN110973645A (en) | Protein powder with brain nerve nutrition function | |
CN110393217A (en) | A kind of nutrient soy milk and its preparation process rich in five cereals | |
WO2008142701A1 (en) | Method of preparation and preservation of soy bean curd with preserved poly unsaturated fatty acid | |
CN107874245A (en) | Lactose intolerance can be avoided and the nutrient powder of nutrition is provided for lactose intolerance crowd | |
CN113749152A (en) | Health preserving and body building drink and preparation method thereof | |
CN112931618A (en) | Pumpkin yoghourt and preparation method thereof | |
CN106261343A (en) | A kind of composite health care beverage with antihypertensive function and preparation method thereof | |
KR100734944B1 (en) | Functional food-composition with calcium lactate and rice bran | |
CN1364418A (en) | Diary product good for brain and reproduced food | |
JP2009034017A (en) | Diet food | |
CN108633996A (en) | A kind of pure plant Yoghourt and preparation method thereof suitable for consumption by infants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07790090 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07790090 Country of ref document: EP Kind code of ref document: A1 |